OTC:RAPH | Cash Flow Statement | Raphael Pharmaceutical Inc.

Complete source-backed cash-flow history.

Available history
2020-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$223,000.00
2026-03-31-$229,000.00-$44,000.00
2025-12-31-$273,000.00$46,000.00-$4,000.00
2025-09-30-$255,000.00
2025-06-30-$322,000.00
2025-03-31-$429,000.00-$209,000.00$240,000.00
2024-12-31-$395,000.00-$62,000.00$41,000.00
2024-09-30-$326,000.00
2024-06-30-$248,000.00
2024-03-31-$550,000.00-$172,000.00$1,000.00-$1,000.00$230,000.00
2023-12-31$62,000.00-$88,000.00$19,000.00
2023-09-30-$725,000.00
2023-06-30-$417,000.00
2023-03-31-$264,000.00-$399,000.00$149,000.00
2022-12-31-$1.1M-$277,000.00$0.00$472,000.00
2022-09-30-$1.44M
2022-06-30-$627,000.00
2022-03-31-$185,000.00-$82,000.00$10,000.00
2021-12-31-$566,000.00-$703,000.00$819,000.00
2021-09-30-$416,000.00
2021-06-30-$387,000.00
2021-03-31-$255,000.00-$129,000.00$44,000.00
2020-12-31-$230,000.00-$468,000.00$527,000.00
2020-09-30-$243,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$1.28M-$210,000.00$236,000.00
2024-12-31-$1.52M-$532,000.00$321,000.00
2023-12-31-$1.34M-$1.2M$1.15M
2022-12-31-$3.36M-$759,000.00$2,000.00-$2,000.00$896,000.00
2021-12-31-$1.62M-$1.42M$1.48M
2020-12-31-$718,000.00-$779,000.00$824,000.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.